The Venture Codex Logo

The Venture Codex

Form Health

109 State St Ste 5, Boston, Massachusetts, 02109, United States

Overview

Form Health delivers science-based obesity care through a 100% virtual telehealth model that pairs an ABOM-certified physician with a Registered Dietitian as a dedicated Care Team. The Care Team develops individualized weight-loss plans addressing nutrition, activity, mindset, and prescribes FDA-approved weight loss medication when appropriate. Since its founding in 2019, Form has provided care to tens of thousands of patients and is in-network with most major insurance plans, including Medicare. The company uses telehealth visits, unlimited messaging, a digital scale, and an interactive app to monitor patients and drive outcomes. Planned uses of new capital include expanding enterprise partnerships with employers, consultants, and health plans, accelerating hiring and training of ABOM-certified physicians, and investing in its telehealth technology and product development. Form emphasizes safety, efficacy, and evidence-based care as it scales. Form Health is a Boston, MA–based obesity telemedicine company that provides a medically supervised weight-loss program combining virtual care from board‑certified physicians with FDA‑approved medications. Each patient is paired with a physician and a registered dietitian trained in obesity management for frequent check‑ins that incorporate medical guidance and behavioral, nutrition, and activity changes. The company employs board‑certified physicians and registered dietitians. Its program is currently available in 21 states, including California, Illinois, New York, Pennsylvania, Texas, and Virginia. As a medical service, reimbursed care may be covered by insurance at little or no cost. Form Health plans to use funding to expand availability to 90% of the U.S. population.

Total raised
$50M
Funding rounds
2
Latest round
Series B
Latest activity
Jun 2024

Industries

  • Health Care
  • Medical
  • Personal Health
Visit website

Recent funding

  1. Series B

    Jun 2024

    $38M

  2. Series A

    Jun 2021

    $12M

Team

  • Evan Richardson

    Founder and CEO

    LinkedIn
  • Florencia Halperin

    Chief Medical Officer

    LinkedIn
  • Christine Ruggieri

    Marketing Director

    LinkedIn
  • Allyn Booher

    Pharmacist in Cahrge: Director

    LinkedIn